Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>Abstract</jats:title><jats:p>The microRNA-34a is a well-studied tumor suppressor microRNA (miRNA) and a direct downstream target of TP53 with roles in several pathways associated with oncogenesis, such as proliferation, cellular growth, and differentiation. Due to its broad tumor suppressive activity, it is not surprising that <jats:italic>miR34a</jats:italic> expression is altered in a wide variety of solid tumors and hematological malignancies. However, the mechanisms by which <jats:italic>miR34a</jats:italic> is regulated in these cancers is largely unknown. In this study, we find that a long non-coding RNA transcribed antisense to the <jats:italic>miR34a</jats:italic> host gene, is critical for <jats:italic>miR34a</jats:italic> expression and mediation of its cellular functions in multiple types of human cancer. We name this long non-coding RNA <jats:italic>lncTAM34a,</jats:italic> and characterize its ability to facilitate <jats:italic>miR34a</jats:italic> expression under different types of cellular stress in both <jats:italic>TP53</jats:italic> deficient and wild type settings.</jats:p>

Original publication




Journal article


Cold Spring Harbor Laboratory

Publication Date